Application of drug-coated balloons in treatment of coronary small vessel diseases
10.3969/j.issn.1674-8115.2018.06.020?
- VernacularTitle:药物涂层球囊在冠状动脉小血管病变中的应用
- Author:
Gan YANG
1
;
Jun PU
;
Ben HE
Author Information
1. 上海交通大学 医学院附属仁济医院心内科
- Keywords:
drug-coated balloon;
drug-eluting stent;
paclitaxel;
coronary small vessel;
percutaneous transluminal coronary angioplasty
- From:
Journal of Shanghai Jiaotong University(Medical Science)
2018;38(6):695-698
- CountryChina
- Language:Chinese
-
Abstract:
Drug-coated balloons (DCB) have emerged as a new application in percutaneous coronary intervention. It is developed to circumvent some of the limitations faced by drug-eluting stents (DES). DES has some limitations, as follows: it could not be implanted in some lesions; bleeding risks are associated with prolonged dual antiplatelet therapy; risks of late and very late stent thrombosis increase. Many clinical trials had confirmed the efficacy and safety of DCB, particularly, the application of DCB in coronary small vessel diseases. This review discussed the basic concept, development, evolution of DCB and some clinical studies associated with the application of DCB in coronary small vessel diseases.
